Montenarh, D; Hopf, M; Warth, S; Maurer, HH; Schmidt, P; Ewald, AH. A simple extraction and LC-MS/MS approach for the screening and identification of over 100 analytes in eight different matrices: Detection of 130 analytes in eight biosamples using only one LC-MS/MS method Drug Test. Anal., 1 Mar 2015, 7 (3), 214-240. 593 kB. https://doi.org/10.1002/dta.1657 LC,MS
Currie, KS. Antianxiety Agents In Burger's Medicinal Chemistry and Drug Discovery; Abraham, DJ, Ed., John Wiley & Sons, Inc., 15 Jan 2003; pp 525–597. 2.7 MB. https://doi.org/10.1002/0471266949.bmc102 #37
Huang, Q; He, X; Ma, C; Liu, R; Yu, S; Dayer, CA; Wenger, GR; McKernan, R; Cook, JM. Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach J. Med. Chem., 1 Jan 2000, 43 (1), 71–95. 912 kB. https://doi.org/10.1021/jm990341r #151
Ntoupa, PA; Papoutsis, II; Dona, AA; Spiliopoulou, CA; Athanaselis, SA. A fluorine turns a medicinal benzodiazepine into NPS: The case of flualprazolam Forensic Toxicol., 1 Jul 2021, 39 (2), 368-376. 795 kB. https://doi.org/10.1007/s11419-020-00565-4 #Triazolam
Clayton, T. Part I. Unified pharmacophore protein models of the benzodiazepine receptor subtypes. Part II. Subtype selective ligands for α5 GABA(A)/BZ receptors Ph. D. Thesis, University of Wisconsin-Milwaukee, 1 Dec 2012. 28.1 MB. #Triazolam
Nakagawasai, O; Arai, Y; Satoh, S; Satoh, N; Neda, M; Hozumi, M; Oka, R; Hiraga, H; Tadano, T. Monoamine oxidase and head-twitch response in mice: Mechanisms of α-methylated substrate derivatives Neurotoxicology, 1 Jan 2004, 25 (1), 223–232. 169 kB. https://doi.org/10.1016/S0161-813X(03)00101-3 #Triazolam